FREITAS, Brennda Rachel Campos e.
Resumen:
The request of drugs via litigation it is an alternative for obtaining a treatment. Finding support in the constitutional right to health and life, this process should not disregard the principles established by the universal system of Brazilian health. Due to the increase of these actions, the field of legalization has been the object of study of interest in several areas, from the public health, through the rights and administration. Thus, the aim of this study was to characterize of the demand for drugs dispensed by courts in the State of Rio Grande do Norte in the period from January to June 2014, in relation to aspects of the Pharmaceutical Care Management. Thus, we developed a cross-sectional study of exploratory nature with quantitative approach. The registered cases were analyzed on the site of the Court, relating to 145 applicants patients. Higher prevalence in females was observed, which most lived in the capital Natal and the others are located in the state. There was a variety of conditions and therefore of requested drugs, which have been analyzed through classifications in ICD-10 and ATC code. The vast majority of prescriptions were from the SUS and the requested medicines were not part of the list of components of pharmaceutical care, however, of those who were in the RENAME, the highest prevalence was for those who belonged to the Specialized Component. The results showed that the requested more prevalently drugs were those that act in the nervous system, followed by antineoplastic and immunomodulating agents. It was found also that more than half of the drugs are not part of public funding lists, and others are in the Specialized Component, noting that most of the lawsuits who disregard the available therapeutic alternatives in the SUS. These results show the need to coordination of the judiciary with the professionals involved in health management, including pharmaceuticals, in order to facilitate patient access to safe and proper treatment, without the realization of the right to health interfere with the effectiveness of public policies aimed medicines to the community.
